Markets
Netherlands: the aanwijzing and the annual mandate
A company on Euronext Amsterdam can issue a convertible priced against the market at each conversion, and can run a drawdown facility. No Dutch pricing formula, minimum price or maximum discount stands in the way. What decides the size of the deal is the aanwijzing: the general meeting's designation of the board as the body competent to issue shares, and to exclude pre-emption.
Key takeaways
- The Dutch move the competence, not just the right. London and Dublin grant an authority to allot and separately disapply pre-emption. A Dutch general meeting can hand the competence to issue to the board by an aanwijzing, and the power to exclude the voorkeursrecht travels with it.
- The designation is time-limited, and that is the clock. It runs for the period the meeting fixes and is renewed at the annual meeting, so a multi-year facility depends on a resolution nobody has voted on yet.
- No pricing rule was found. No Dutch minimum issue price computed from a trading average, and no maximum discount, was located for a listed NV. Price is a board decision, not a formula.
- Below par is the one hard floor. Article 47 of Directive (EU) 2017/1132: shares may not be issued at a price lower than nominal value or accountable par.
- Nothing found from the AFM is not the same as approval. No Dutch equivalent of the AMF study or the FSMA communication was located for this page, and that absence carries no weight either way.
How an Amsterdam issue is authorised
The Dutch naamloze vennootschap starts from a different place than its common-law neighbours. Issuing shares is a power of the algemene vergadering, the general meeting, and the meeting may designate another corporate body to exercise it. That designation, the aanwijzing, is what turns a Dutch board into an issuer. Alongside it travels the ability to limit or exclude the voorkeursrecht, the shareholders' pre-emptive right on a cash issue.
The practical consequence is that a Dutch financing conversation begins with two documents, not with a term sheet: the resolution that designated the board, and the date it expires. An investor negotiating a facility with a Dutch issuer is negotiating against that expiry. Where the designation is thin, the alternative is the claimemissie, a rights issue to existing holders, which is slower, more expensive and available to everyone — and therefore a different transaction altogether.
What actually caps a Dutch facility
Not a statute. The Dutch ceiling is governance: how much non-pre-emptive issuance capacity institutional shareholders will vote for in a year, and how strictly they read the request. Eumedion, the Dutch institutional investors' governance forum, and the international proxy advisers publish positions that Dutch boards plan around, and a request materially above the settled expectation becomes a governance conversation months before it becomes a financing.
| Requirement | Where it comes from | What it means for a multi-year facility |
|---|---|---|
| Competence to issue | The aanwijzing voted by the general meeting | Expires; must be renewed before the last drawdown |
| Exclusion of the voorkeursrecht | The general meeting, or a board designated for the purpose | Sized in the same resolution, and spent as it is used |
| Headroom the market will support | Institutional governance policy, not law | The real ceiling on facility size |
| Issue price | No statutory floor found, except nominal value | A market-referenced price is available |
| Follow-on admission | Prospectus Regulation, as amended by the EU Listing Act | Exempt below 30% of the class already admitted over 12 months |
| Structural summary only. The articles of association and the resolution actually passed govern. | ||
Nominal value, and the corporate action that comes first
The floor that does bind is European. Article 47 of Directive (EU) 2017/1132 provides that shares may not be issued at a price lower than their nominal value or accountable par. A Dutch company trading in cents against a nominal value of a euro cannot issue at the market, whatever the facility says, until it reduces the nominal value. That is a separate corporate action with its own resolution and its own timetable, and it belongs at the front of the process rather than in a condition precedent. The same manoeuvre appears as a capital reduction in Germany and as a deferred-share subdivision in the United Kingdom.
Dealing, and what the register looks like afterwards
Shares issued to an investor are freely transferable on admission to Euronext Amsterdam. There is no Dutch holding period and no resale registration, so an investor drawing under a share subscription facility or a committed equity facility is trading days from liquidity rather than filings — the opposite of the US position on Rule 144 and restricted securities. That cuts the discount an investor needs, and it also means an issuer should model the selling pressure honestly rather than assume a long-term holder.
General information, not legal advice. The Dutch Civil Code was not read in primary form for this page, so no article number, majority or maximum designation period is given. The statements here about the aanwijzing and the voorkeursrecht are architectural and must be confirmed against Book 2 of the Burgerlijk Wetboek. Take advice from qualified Dutch counsel before acting.
This verdict is provisional. The permissive reading rests on the EU capital framework that applies to every Dutch listed company, not on a Dutch primary text read for this note. Because of that, this page makes no machine-readable capability claim for the Netherlands, and the entry should be treated as a screen to be confirmed rather than a finding.
Send the designation resolution and its expiry date and we will size a structure that finishes before it does.
Sources
- Directive (EU) 2017/1132, Article 47
- Regulation (EU) 2024/2809 — the EU Listing Act
- Autoriteit Financiele Markten
- Eumedion — Dutch institutional investors' governance forum
Financing a Dutch listed issuer: frequently asked questions
Does Dutch law cap the discount on a share issue?
No Dutch maximum discount, and no minimum issue price by reference to a trading average, was found for a company listed on Euronext Amsterdam. The floor that certainly applies is nominal value: shares may not be issued below their nominal value or accountable par. Beyond that, price is a matter for the board acting within its mandate and its duties.
What is an aanwijzing?
It is the general meeting's designation of another corporate body, in practice the management board, as the body competent to issue shares. It is granted for a fixed period and then renewed, which is why the annual general meeting rather than the facility agreement sets the horizon of a Dutch drawdown programme.
Can a Dutch issuer exclude pre-emption in favour of one investor?
Yes. The voorkeursrecht on a cash issue may be restricted or excluded by the general meeting, or by the board where the board has been designated for that purpose. The practical question is not whether it can be done, but how much headroom the meeting was willing to grant and when that headroom expires.
Has the AFM warned about dilutive convertible financing?
No AFM publication comparable to the AMF study of October 2022 or the FSMA communication of February 2023 was found for this page. That is the result of a search rather than a statement that the AFM has said nothing, and it should not be read as approval of any structure.
Talk to us
When does the aanwijzing run out?
The designation that lets the board issue shares and exclude the voorkeursrecht, not the term sheet, is the outer edge of a Dutch facility. Send its expiry date with the free float and the nominal value.